earnings
confidence high
sentiment positive
materiality 0.85
SS Innovations Q1 revenue $11.1M (+117% YoY); net loss narrows to $3.6M; installations up 73%
SS Innovations International, Inc.
2026-Q1 EPS reported
-$0.02
revenue$11,101,366
- Revenue $11.1M, up 116.8% YoY from $5.1M; gross margin 48.0% vs 21.2% in Q1 2025.
- Net loss $3.6M ($0.02/share) vs $5.7M ($0.03) in Q1 2025; cash $16.0M, no long-term debt.
- SSi Mantra installations 26 (+73% YoY); cumulative installed base 194 across 11 countries; 9,744 cumulative surgeries.
- Regulatory approvals: NMRA (Sri Lanka) and PPB (Kenya); telesurgery approvals in Indonesia and Philippines.
- March 2026 private placement raised ~$18.6M gross; FDA 510(k) review expected in 2026 and CE marking pathway.